179 related articles for article (PubMed ID: 2910964)
21. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
23. Topical minoxidil therapy for hereditary male pattern alopecia.
Roenigk HH; Pepper E; Kuruvilla S
Cutis; 1987 Apr; 39(4):337-42. PubMed ID: 3556042
[TBL] [Abstract][Full Text] [Related]
24. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
26. Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer.
Phillips GS; Freret ME; Friedman DN; Trelles S; Kukoyi O; Freites-Martinez A; Unger RH; Disa JJ; Wexler LH; Tinkle CL; Mechalakos JG; Dusza SW; Beal K; Wolden SL; Lacouture ME
JAMA Dermatol; 2020 Sep; 156(9):963-972. PubMed ID: 32756880
[TBL] [Abstract][Full Text] [Related]
27. Topical minoxidil therapy in hereditary androgenetic alopecia.
De Villez RL
Arch Dermatol; 1985 Feb; 121(2):197-202. PubMed ID: 3883902
[TBL] [Abstract][Full Text] [Related]
28. Cyclic dynamics of hair follicles and the effect of minoxidil on the bald scalps of stumptailed macaques.
Uno H; Cappas A; Schlagel C
Am J Dermatopathol; 1985 Jun; 7(3):283-97. PubMed ID: 4051135
[No Abstract] [Full Text] [Related]
29. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
[TBL] [Abstract][Full Text] [Related]
30. A new approach to treating scarring alopecia by hair transplantation and topical minoxidil.
Tyagi V; Singh PK
Indian J Dermatol Venereol Leprol; 2010; 76(2):215. PubMed ID: 20228566
[No Abstract] [Full Text] [Related]
31. The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study.
Gong L; Bao L; Tian T; Li Y
J Cosmet Laser Ther; 2018 Feb; 20(1):58-63. PubMed ID: 29166130
[TBL] [Abstract][Full Text] [Related]
32. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
33. The stumptailed macaque as a model for androgenetic alopecia: effects of topical minoxidil analyzed by use of the folliculogram.
Brigham PA; Cappas A; Uno H
Clin Dermatol; 1988; 6(4):177-87. PubMed ID: 3063370
[No Abstract] [Full Text] [Related]
34. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A
Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262
[TBL] [Abstract][Full Text] [Related]
35. Effect of minoxidil on hair transplantation in alopecia androgenetica.
Singh G
Indian J Dermatol Venereol Leprol; 1998; 64(1):23-4. PubMed ID: 20921704
[TBL] [Abstract][Full Text] [Related]
36. Histologic response to topically applied minoxidil in male-pattern alopecia.
Abell E
Clin Dermatol; 1988; 6(4):191-4. PubMed ID: 3214821
[No Abstract] [Full Text] [Related]
37. Treatment of female androgenetic alopecia with minoxidil 2%.
Whiting DA; Jacobson C
Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
[TBL] [Abstract][Full Text] [Related]
38. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
[TBL] [Abstract][Full Text] [Related]
39. The potential role of minoxidil in the hair transplantation setting.
Avram MR; Cole JP; Gandelman M; Haber R; Knudsen R; Leavitt MT; Leonard RT; Puig CJ; Rose PT; Vogel JE; Ziering CL;
Dermatol Surg; 2002 Oct; 28(10):894-900; discussion 900. PubMed ID: 12410672
[TBL] [Abstract][Full Text] [Related]
40. Topical minoxidil in the treatment of androgenetic alopecia in women.
Olsen EA
Cutis; 1991 Sep; 48(3):243-8. PubMed ID: 1935254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
